Evidence map›Paper›PMID 40188480›Full record

ArticleThe ISME journal2025

Phage-phage competition and biofilms affect interactions between two virulent bacteriophages and Pseudomonas aeruginosa.

Magdalena Bürkle, Imke H E Korf, Anne Lippegaus, Sebastian Krautwurst, Christine Rohde, Chantal Weissfuss, Geraldine Nouailles, Xavière Menatong Tene, Baptiste Gaborieau, Jean-Marc Ghigo and 7 more

Abstract read
In one paragraph

Article in The ISME journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Intracellular barriers and receptor masking limit success of abioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Phage-Based Approaches to ChronicAntibiotics (Basel, Switzerland) · 2026
    Review
  8. Antibiotics (Basel, Switzerland) · 2026
    Article
  9. Impact ofAntimicrobial agents and chemotherapy · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Magdalena BürkleDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0002-4767-2942
Imke H E KorfPharmaceutical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine, 38124 Braunschweig, Germany.ORCID 0000-0001-6073-9307
Anne LippegausGeneral Microbiology, Institute of Microbiology, Friedrich Schiller University, 07745 Jena, Germany.ORCID 0000-0001-8492-1947
Sebastian KrautwurstGeneral Microbiology, Institute of Microbiology, Friedrich Schiller University, 07745 Jena, Germany.ORCID 0000-0002-9413-5701
Christine RohdeClinical Phages and Regulations, Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany.
Chantal WeissfussDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0003-3701-3190
Geraldine NouaillesDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0003-1973-3119
Xavière Menatong TeneBacteriophage Bacterium Host, Department of Microbiology, Institut Pasteur, Université Paris-Cité, CNRS UMR6047, 75015 Paris, France.
Baptiste GaborieauBacteriophage Bacterium Host, Department of Microbiology, Institut Pasteur, Université Paris-Cité, CNRS UMR6047, 75015 Paris, France.ORCID 0000-0002-9586-3014
Jean-Marc GhigoGenetics of Biofilms Laboratory, Department of Microbiology, Institut Pasteur, Université Paris-Cité, UMR CNRS 6047, 75015 Paris, France.ORCID 0000-0001-6528-118X
Jean-Damien RicardInfection Antimicrobials Modelling Evolution, Université Paris Cité, Inserm, UMR 1137, 75018 Paris, France.ORCID 0000-0003-1828-2299
Andreas C HockeDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0002-6935-8612
Kai PapenfortGeneral Microbiology, Institute of Microbiology, Friedrich Schiller University, 07745 Jena, Germany.ORCID 0000-0002-5560-9804
Laurent DebarbieuxBacteriophage Bacterium Host, Department of Microbiology, Institut Pasteur, Université Paris-Cité, CNRS UMR6047, 75015 Paris, France.ORCID 0000-0001-6875-5758
Martin WitzenrathDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0002-9787-5633
Sandra-Maria WienholdDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0001-5655-4350
Gopinath KrishnamoorthyDepartment of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0002-0617-6897

Funding

Agence Nationale de la Recherche, FranceBundesministerium für Bildung und Forschung ANR-19-AMRB-0002European Research Council ArtRNA, CoG-101088027Mukoviszidose Institut GmbH P2201
6 · The paper itself

Abstract

Virulent bacteriophages (or phages) are viruses that specifically infect and lyse a bacterial host. When multiple phages co-infect a bacterial host, the extent of lysis and dynamics of bacteria-phage and phage-phage interactions are expected to vary. The objective of this study is to identify the factors influencing the interaction of two virulent phages with different Pseudomonas aeruginosa growth states (planktonic, an infected epithelial cell line, and biofilm) by measuring the bacterial time-kill and individual phage replication kinetics. A single administration of phages effectively reduced P. aeruginosa viability in planktonic conditions and infected human lung cell cultures, but phage-resistant variants subsequently emerged. In static biofilms, the phage combination displayed initial inhibition of biofilm dispersal, but sustained control was achieved only by combining phages and the meropenem antibiotic. In contrast, adherent biofilms showed tolerance to phage and/or meropenem, suggesting a spatio-temporal variation in the phage-bacterial interaction. The kinetics of adsorption of each phage to P. aeruginosa during single or co-administration were comparable. However, the phage with the shorter lysis time depleted bacterial resources early and selected a specific nucleotide polymorphism that conferred a competitive disadvantage and cross-resistance to the second phage. The extent and strength of this phage-phage competition and genetic loci conferring phage resistance are, however, P. aeruginosa genotype-dependent. Nevertheless, adding phages sequentially resulted in their unimpeded replication with no significant increase in bacterial host lysis. These results highlight the interrelatedness of phage-phage competition, phage resistance, and specific bacterial growth state (planktonic/biofilm) in shaping the interplay among P. aeruginosa and virulent phages.

Indexed as

BacteriophagesBiofilmsMicrobial InteractionsPseudomonas aeruginosaPseudomonas PhagesAnti-Bacterial AgentsCell LineEpithelial CellsHumansMeropenemMicrobial ViabilityAnti-Bacterial AgentsMeropenembacteria–phage interactionscystic fibrosisphage–phage competitionphage resistancephage therapypneumonia

Identifiers

PMID40188480
PMCPMC12041424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.